Important safety considerations include the risk of acute pancreatitis (seek urgent medical advice for severe, persistent abdominal pain), gallbladder disease, dehydration leading to acute kidney injury from gastrointestinal effects, and potential worsening of diabetic retinopathy with rapid improvement in blood glucose control
Olatorepatide (Hs-20094) Achieves Up To 19.3% Weight Loss At Week 48 In Phase 3 Study With Favourable Gastrointestinal Tolerability, 07 March 2026, Olatorepatide (HS-20094) Achieves Up to 19.3% Weight Loss at Week 48 in Phase 3 Study with Favorable Gastrointestinal Tolerability-Press Releases-Hansoh Pharmaceutical Group Co., Ltd
This holistic evaluation ensures GLP-2 and GLP-3 is the right fit for you
Vitamin B-12 is needed to support a healthy metabolism and the breakdown of foods within the stomach
Common Side Effects Nausea Diarrhea Vomiting Constipation Stomach pain Decreased appetite Headache Serious Side Effects (Less Common) Pancreatitis (pancreatic inflammation) Gallbladder issues Kidney injuries (often from dehydration linked to nausea) Severe allergic reactions Vision changes in type 2 diabetes patients Increased heart rate Oral semaglutide carries a boxed warning concerning the risk of thyroid C-cell tumors based on animal studies
Structure-guided activity enhancement and catalytic mechanism of yeast grx8